help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacLeod, J. N.
Right arrow Articles by Cooke, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacLeod, J. N.
Right arrow Articles by Cooke, N. E.

Endocrinology, Vol 128, 1298-1302, Copyright © 1991 by Endocrine Society

ARTICLES

Human growth hormone-variant is a biologically active somatogen and lactogen

JN MacLeod, I Worsley, J Ray, HG Friesen, SA Liebhaber and NE Cooke
Department of Human Genetics, University of Pennsylvania, Philadelphia 19104-6144.

The human GH-variant (hGH-V) gene, a member of the GH-PRL gene family, is expressed by the placenta during the second and third trimesters of gestation. The secreted hGH-V protein differs from pituitary GH (hGH-N) by only 13 amino acids. We have previously demonstrated that hGH-V can bind to both somatogen and lactogen cell surface receptors in vitro, but that the ratio of its somatogen to lactogen receptor-binding affinities is substantially higher than that of hGH-N. We now characterize the somatogen and lactogen bioactivities of hGH-V and contrast them to the bioactivity of hGH-N. Somatogen bioactivity was assayed by stimulation of weight gain in hypophysectomized rats, and lactogen bioactivity was assayed by the mitogenic response of the Nb2 lymphoma cell line. While the average increase in rat body weight in response to a fixed concentration of hormone was comparable using either hGH-V or hGH-N, the mitotic response of the lactogen-inducible Nb2 cells was significantly less for hGH-V. The comparable somatogen, but lower lactogen, bioactivity of hGH-V relative to hGH-N parallels the previously reported receptor binding profiles of the two hormones and suggests that hGH-V has the potential to perform a unique role during human gestation.


This article has been cited by other articles:


Home page
 Mol. Cell. Biol.Home page
A. P. Kimura, D. Sizova, S. Handwerger, N. E. Cooke, and S. A. Liebhaber
Epigenetic Activation of the Human Growth Hormone Gene Cluster during Placental Cytotrophoblast Differentiation
Mol. Cell. Biol., September 15, 2007; 27(18): 6555 - 6568.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
I. Atwater, B. Gondos, R. DiBartolomeo, R. Bazaes, and L. Jovanovic
Pregnancy Hormones Prevent Diabetes and Reduce Lymphocytic Infiltration of Islets in the NOD Mouse
Ann. Clin. Lab. Sci., January 1, 2002; 32(1): 87 - 92.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society